semaj83/ctmatch_classification huggingface dataset:
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abrasion of Soft Palate Intubation Complication Informed patient consent ASA I III Age > 18 years Elective surgery, other than head and/or neck surgery Pre-operative Mallampati I III BMI < 35 kg/m2 Fasted (≥6 hours)  No informed patient consent ASA ≥ IV Age < 18 year Emergency surgery, surgery of head and/of neck Locoregional anaesthesia Pre-operative Mallampati IV BMI > 35 kg/m2 Fasted < 6 hours Pre-operative expected difficult airway (restrict neck movement, thyromental distance < 65mm, retrognathia) Bad, fragile dentition
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 0.0-5.0,  Infections, Rotavirus Continuously enrolled from birth. (Note: Due to the absence of birth dates in insurance claims data, this criterion will be met if a child's year of first enrollment and year of birth are the same. If so, then the date of first enrollment will be used as proxy for date of birth.) Received both medical and pharmacy benefits  Enrolled in capitation-based health plans For MarketScan Commercial, residence in states with universal vaccination programs that the RV vaccine or where RV vaccine cannot be ascertained (i.e., Alaska, Idaho, Massachusetts, Maine, North Dakota, New Hampshire, New Mexico, Oregon, Rhode Island, Vermont, Washington, Wisconsin, and Wyoming) Lost to follow-up or had RV prior to 6 weeks of age
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Peritonsillar Abscess Older than 18 years of age Diagnosed with a peritonsillar abscess that has been drained and purulence has been obtained  Pregnant Under the age of 18 Bilateral peritonsillar abscesses Recently drained peritonsillar abscess Immunocomprimised
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Streptococcus Pneumoniae Neisseria Meningitidis Haemophilus Influenzae Subjects who the investigator believes can and will comply with the requirements of the protocol or subjects who the investigator believes that parent(s)/Legally Acceptable Representative(s) [LAR(s)] can and will comply with the requirements of the protocol Written informed consent obtained from the subject/from the parent(s)/LAR of the subject A male or female subject who visits the hospital with suspected bacterial meningitis CSF sample taken as part of routine practice  Child in care
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Airway Morbidity ASA (American Society of Anesthesiologists patient fitness category) I, II, III Age 18-70 General anesthetic for where LMA placement is not contraindicated will be included  Small mouth opening Preoperative sore throat/dysphagia/dysphonia Patients at increased risk for aspiration Morbid obesity BMI > 40 Untreated chronic GERD Pregnancy Suspected supraglottic abnormalities N2O use Need for oral-pharyngeal suctioning Undergoing oral and nasal surgery
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Recurrent Tonsillitis Recurrent Peritonsillar Abscess Obstructive Sleep Apnea Any adult patient who meets and is scheduled for tonsillectomy  Any patient with prior use of acupuncture Individuals under age 18 Tonsillectomy performed with other surgical procedures, i.e UPPP, adenoidectomy Patients with a known personal or family history of a bleeding disorder will be excluded Patients with a history of kidney or liver problems will also be excluded Patients found to be pregnant will be excluded from participation Patients unwilling to enroll in the study will have the tonsillectomy with or without adenoidectomy performed according to current practice standards
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Sleep Apnea, Obstructive for OSA Patients OSA (elevated AHI) Age range 18-70 years  Any known cardiac (apart from treated hypertension), pulmonary (including asthma), renal, neurologic (including epilepsy), neuromuscular, or hepatic disease Susceptible to stomach ulcers Pregnant women History of hypersensitivity to Afrin, Lidocaine, trazodone and/or donepezil History of bleeding diathesis and/or gastrointestinal bleeding Use of any medications that may affect sleep or breathing A psychiatric disorder, other than mild depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders Substantial cigarette (>5/day), alcohol (>3oz/day) or use of illicit drugs More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day Desaturations to below 70% lasting greater than 10 seconds in duration per event on polysomnography
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 60.0-85.0,  Pulmonary Aspiration Age 60-85 years' old Both male and female patients ASA I-II Body mass index (BMI) ≤ 30 kg/m2 Elective surgery under general anaesthesia with the use of laryngeal mask airway (LMA) / LMA Proseal / LMA Supreme Type of surgery: Urogynecological, General Surgery, Orthopedics, Eye, Vascular, Plastic Surgery/anaesthesia lasting for 0.5-3 hours  Patients with difficulty in swallowing, preexisting neuromuscular or central nervous system disorder Patients undergoing intra abdominal, thoracic, face, nasal or throat surgery Known condition interfering with gastric emptying Patients with cognitive or hearing impairment and inability to provide informed consent ASA III-IV patients Use of muscle relaxant during the course of general anesthesia Contraindication or previous adverse response to any of the study drugs
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Esophageal Cancer age ≥ 18 years dysphagia due to unresectable esophageal cancer participant resides within 50 km of Tenwek Hospital tumor is ≤ 9 cm in length and > 2 cm distal to the upper esophageal sphincter (UES) no esophago-respiratory fistula (ERF) or suspected perforation is present  unable to provide written informed consent
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 3.0-9.0,  Nasopharyngeal Carriage of Streptococcus Pneumoniae for FinIP-vaccinated children age 3 to 5 years enrolled in the FinIP trial and has received at least one dose of study vaccine in the infant vaccine schedule (3+1 or 2+1) at least one parent with fluent Finnish informed consent from one parent  for FinIP-vaccinated children PCV vaccination administered, other than the randomized study vaccine history of antimicrobial treatment within 4 weeks (the child can be enrolled later) for unvaccinated siblings age 5 to 9 years younger sibling living in the same household having participated in the FinIP trial (regardless of the vaccination schedule) at least one parent with fluent Finnish informed consent from one parent for unvaccinated siblings PCV vaccination administered
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 3.0-9.0,  Pain Postoperative, Intraoperative Hemorrhage children aged 3-9 years American Society of Anesthesiologists 1-2 status, scheduled for adenotonsillectomy  Children with systemic disease, metabolic and endocrin disorders, growth developmental and motor-mental retardation, those who had a history of allergy to any of the study drugs, peritonsillar abscess, hypertension, psychiatric and epileptic disorders, chronic pain syndrome, and those who received analgesics within 24 h prior to surgery were excluded from study
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 20.0-60.0,  Voice Disorders Age between 20-60 No occurence of speech therapy simultaneously to the intervention  Professional voice use in another activity Frequent use of alcohol and tobacco Influenza and/or upper respiratory tract infections (eg, rhinitis, sinusitis, pharyngitis) during the period of participation in the research
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 4.0-11.0,  Vocal Fold Nodules Diagnosis of vocal fold nodules Age 4-11 yr Informed Consent English comprehension and production sufficient to participate in the protocol and in voice therapy Considered behaviorally and cognitively appropriate by the ear, nose, and throat physician and speech-language pathologist for voice therapy Parent and child willingness to participate in all aspects of the protocol and voice therapy  Co-morbid medical conditions or medications that would mask or amplify the outcome of voice therapy, including (a) developmental or other neuromuscular conditions, (b) major illness, chronic or acute, with the exception of laryngopharyngeal reflux disease (LPR) or allergies and their treatments, which are common in both children and adults with voice disorders, thus their would severely restrict the participant pool and, moreover, threaten external validity Hearing loss: > 20 dB hearing loss at 1000, 2000, 4000 Hz in at least one ear
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Obstructive Sleep Apnea Ages 18-70 years sleep study (with apnea hypopnea index>5) Diagnosis of obstructive sleep apnea  Any known unstable cardiac (apart from treated hypertension), pulmonary (including asthma), renal, neurologic (including epilepsy), neuromuscular, or hepatic disease Susceptible to stomach ulcers Pregnant women or Nursing mothers Using positive airway pressure (PAP) therapy over one week or longer Body weight <55kg History of hypersensitivity to Afrin, Lidocaine and/or Donepezil History of bleeding diathesis and/or gastrointestinal bleeding Use of any medications that may affect sleep or breathing A psychiatric disorder, other than mild depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders Substantial cigarette (>5/day), alcohol (>3oz/day) or use of illicit drugs
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 0.083-65.0,  Abscess Soft tissue abscess suspected by patient history and physical exam and confirmed by bedside ultrasound Able to provide written consent/ assent Incision and drainage to be performed by ED physician  Peritonsillar abscess Pilonidal cyst, genital or perirectal abscess Post-surgical wound infections Pregnant Prisoners Previous incision and drainage for current abscess
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 2.5-4.0,  Premature Birth Child was born between 26 and 37 weeks gestational age Infant is a singleton (matched between groups) Mother is 18 years of age or older Mother has at least one supporting person in the home (e.g. significant other, mother, father, sibling, aunt, grandmother, step-parent) Child demonstrates developmental deficit (language, cognition, motor, emotion)  The child has severe congenital anomalies including chromosomal anomalies The child has severe motor or physical disability Mother currently presents with psychosis or is currently taking antipsychotic medication Status of enrolled subject changes and subject no longer falls in Mother and/or infant has a medical condition that precludes intervention components Mother and/or infant has a contagion that endangers other participants in the study
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Sleep Apnea, Obstructive Healthy control subjects  Cardiovascular disease other than well controlled hypertension Depression
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Sleep Apnea, Obstructive Diagnosed OSA (moderate-to-severe; apnea hypopnea index >15 events/hr)  Cardiovascular disease other than well controlled hypertension Depression
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 2.0-3.917,  Autism Spectrum Disorder Diagnosis of autism Currently do not emit vocalizations or minimally verbal Willingness of the participant's parent/guardian to bring their child to the Marcus Autism Center for one-hour appointments, five days a week, for six weeks  Children with significant problem behavior that interferes with structured intervention
Patient description: A 5-year-old boy presents to the emergency department with complaints of progressively worsening dysphagia, drooling, fever and vocal changes. He is toxic-appearing, and leans forward while sitting on his mother's lap. He is drooling and speaks with a muffled "hot potato" voice. The parents deny the possibility of foreign body ingestion or trauma, and they report that they are delaying some of his vaccines.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Sialorrhea Seeking treatment for troublesome sialorrhea for at least 3 months that is occurring secondary to any disorder or related to any cause, including, but not limited to, Parkinson's Disease (PD), adult cerebral palsy, amyotrophic lateral sclerosis (ALS), stroke, traumatic brain injury, oral cancer, and side effects of other medications Able to read and provide written informed consent before enrollment into the study, or the subject's caregiver (Legally Authorized Representative) can provide written informed consent Male or female, 18 to 85 years of age (inclusive) Minimum unstimulated salivary flow rate of 0.2 g/min at screening Minimum Investigator's Drooling Frequency and Severity Scale (DFSS) score of 4 at screening Ability and availability to participate in the study for up to 1 year (ALS subjects: ability and availability to participate in the study for at least 6 months), based on overall health of the subject and disease prognosis  A moderate to high risk of aspiration will participation in this study. Subjects whose risk of aspiration are judged by the Investigator to be satisfactorily controlled by placement of PEG tube or G-tube for nutritional support are eligible to participate Respiratory forced vital capacity (FVC) of <20% of predicted Prior botulinum toxin type A or B treatment in the salivary gland(s) identified for treatment in this study within 24 weeks before screening. Prior botulinum toxin type A or B treatment into other anatomical regions not selected for treatment in this study is not exclusionary, but must have occurred at least 12 weeks before screening Subjects should be excluded if, in the Investigator's opinion, the subject failed to respond to previous treatment with botulinum toxin. Subjects should not receive nor have any plans for receiving any botulinum toxin treatment, other than the study drug (MYOBLOC), during the entire course of the study (from the point the informed consent is signed until subject's participation is complete) Concomitant use, or exposure within 5 half-lives of screening, of aminoglycoside antibiotics, curare-like agents, or other agents that interfere with neuromuscular function Prior salivary gland surgery Current treatment or treatment at any time during the study with Coumadin® (warfarin) or similar anti-coagulant medications. Anti-platelet medications are not specifically exclusionary Evidence of any clinically significant neurologic disease Pregnancy or lactation Anticipated or scheduled surgery during the study period. A PEG tube/G tube may be placed for nutritional support at any time during the study and will not the subject from continued study participation